Evidence map›Paper›PMID 33409886›Full record

ArticleJournal of general internal medicine2021

How Well Does the Surprise Question Predict 1-year Mortality for Patients Admitted with COPD?

Dana Tripp, Jaclyn Janis, Benjamin Jarrett, F Lee Lucas, Tania D Strout, Paul K J Han, Isabella Stumpf, Rebecca N Hutchinson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Dana TrippTufts University School of Medicine, Boston, MA, USA.
Jaclyn JanisCenter for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.
Benjamin JarrettDivision of Pulmonary Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
F Lee LucasCenter for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.
Tania D StroutTufts University School of Medicine, Boston, MA, USA.
Paul K J HanTufts University School of Medicine, Boston, MA, USA.
Isabella StumpfTufts University School of Medicine, Boston, MA, USA.
Rebecca N HutchinsonTufts University School of Medicine, Boston, MA, USA. rhutchinso@mmc.org.ORCID 0000-0002-9121-6426
Tufts University · USMaine Medical Center · USUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with chronic obstructive pulmonary disease (COPD) often receive burdensome care at end-of-life (EOL) and infrequently complete advance care planning (ACP). The surprise question (SQ) is a prognostic tool that may facilitate ACP.

objectiveTo assess how well the SQ predicts mortality and prompts ACP for COPD patients.

designRetrospective cohort study. SUBJECTS: Patients admitted to the hospital for an acute exacerbation of COPD between July 2015 and September 2018. MAIN MEASURES: Emergency department (ED) and inpatient clinicians answered, "Would you be surprised if this patient died in the next 30 days (ED)/one year (inpatient)?" The primary outcome measure was the accuracy of the SQ in predicting 30-day and 1-year mortality. The secondary outcome was the correlation between SQ and ACP (palliative care consultation, documented goals-of-care conversation, change in code status, or completion of ACP document). KEY

resultsThe 30-day SQ had a high specificity but low sensitivity for predicting 30-day mortality: sensitivity 12%, specificity 95%, PPV 11%, and NPV 96%. The 1-year SQ demonstrated better accuracy for predicting 1-year mortality: sensitivity 47%, specificity 75%, PPV 35%, and NPV 83%. After multivariable adjustment for age, sex, and prior 6-month admissions, 1-year SQ+ responses were associated with greater odds of 1-year mortality (OR 2.38, 95% CI 1.39-4.08) versus SQ-. One-year SQ+ patients were more likely to have a goals-of-care conversation (25% vs. 11%, p < 0.01) and complete an advance directive or POLST (46% vs. 23%, p < 0.01). After multivariable adjustment, SQ+ responses to the 1-year SQ were associated with greater odds of ACP receipt (OR 2.67, 95% CI 1.64-4.36).

conclusionsThe 1-year surprise question may be an effective component of prognostication and advance care planning for COPD patients in the inpatient setting.

Indexed as

Advance Care PlanningPulmonary Disease, Chronic ObstructiveHospitalizationHumansPalliative CareProspective StudiesRetrospective Studiesadvance care planningchronic obstructive pulmonary diseasegoals-of-careprognosticationsurprise question

Identifiers

PMID33409886
PMCPMC8390592
OpenAlexW3033012859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.